Retrieved from http://www.cancer.gov/cancertopics/factsheet/prevention/HPV-vaccine National Cancer Institute. (2012). Pap and HPV Testing. Retrieved from http://www. cancer.gov/cancertopics/factsheet/detection/Pap-HPV-testing World Health Organization.
3. Slota, M., Lim, J., Dang, Y. & Disis, M.L. ELISpot for measuring human immune responses to vaccines. Expert Rev Vaccines 10, 299-306 (2011).
Clinical infectious diseases. 2010;51(10):1201--1208. 2. Papatheodoridis G, Buti M, Cornberg M, LA H, Janssen D, Pol S et al. Corrigendum to:‘‘EASL clinical practice guidelines: Management of chronic hepatitis B virus infection’’[J Hepatol 2012; 57: 167--185].
Since such little information was known about it, HPV was not even taught in the Sexual Education class as a sexually transmitted virus. Throughout years of research scientists, doctors, and medical staff have discovered what HPV is, how one contracts the virus, the symptoms or lack of symptoms, treatment and prevention for HPV. In the United States and the world, HPV has become one of the most commonly sexually transmitted diseases. According to the California Medical Association (CMA), approximately 20 million people are currently infected with HPV, with an estimated 6.2 million new genital HPV infections each year (CMA). There are about 100 different subtypes of HPV in which thirty-forty of the subtypes can infect the genital area.
Staphylococcus aureus colonization: Modulation of host immune response and impact on human vaccine design. Frontiers in Immunology, 4, . doi:10.3389/fimmu.2013.00507 (Brown, Leech, Rogers, & McLoughlin, 2014) Cesur, S., & Eokca, F. (2004). Nasal carriage of Methicillin‐Resistant staphylococcus aureus among hospital staff and Outpatients •. Infection Control and Hospital Epidemiology, 25(2), 169–171.
“Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.” Laryngoscope, 119(08):1542–1549. Retrieved on 12 April 2012 from http://www.ncbi.nlm.nih. gov/pubmed/19522004. 04. Van Monsjou, H.S., M.L.
Advances in treatment of bacterial meningitis. The Lancet,380(9854), 1693-702. doi:http://dx.doi.org/10.1016/S0140-6736(12)61186-6 Waghdhare, S., Kalantri, A., Joshi, R., & Kalantri, S. (2010). Accuracy of physical signs for detecting meningitis: A hospital-based diagnostic accuracy study. Clinical Neurology and Neurosurgery, 112(9), 752-7. doi:http://dx.doi.org/10.1016/j.clineuro.2010.06.003
Pediatric Drugs, 10(6), 367-378. Witte, W. W. (2009). Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?. Clinical Microbiology & Infection, 1517-25. doi:10.1111/j.1469-0691.2009.03097.x
Journal of Leukocyte Biology. 2012. p. 27–33. 9. García F, Climent N, Assoumou L, Gil C, González N, Alcamí J, et al. A therapeutic dendritic cell-based vaccine for HIV-1 infection.